HOME > Programme

XI International Facial Nerve Symposium

SCIENTIFIC PROGRAMME

As this is the preliminary programme it may be subject to changes, so make sure you check for updates.

 

 

Monday, April 27th, 2009

08.30 - 08.50
KEYNOTE LECTURE
  Chairman: B. Fraysse, France
PLENARY Hemangioma of the geniculate ganglion
D.E. Brackmann, USA
09.00 - 10.00
PANEL:  FACIAL HEMISPASM (PLENARY)
  Moderator: WH Slattery, USA
Participants: Magnan, France M. Samii, R. Laskawi Germany
09.00 - 10.30
FACIAL NERVE SCHWANNOMA (CAETANI)
  Chairmen: M. Kameswaran, India - C.S. Kim, Korea
09.00-09.08 Facial nerve schwannomas G. Lamas, MA Trogu, F. Tankere, P. Gatignol, JC Willer, France
09.10-09.18 Treatment of facial nerve neuroma: a paradigm shift
DE Brackmann, EP Wilkinson, WH Slattery, USA
09.20-09.28 Management of facial nerve tumors
D. Bernardeschi, I. Bernat, I Mosnier, M. Kalamarides,
A. Bozorg-Grayeli, O. Sterkers, France
09.30-09.38 Facial nerve tumors F. Trabalzini, G. Babighian, Italy
09.40-09.48 Facial nerve schwannoma: can we preserve the function after surgery? S. Lee, DB  Shin, J. Kim, IS Moon, JD Lee, Korea
09.50-09.58 Management of facial nerve neuroma M. Kameswaran, K. Natarajan, S. Raghunandan, India
10.00-10.08 Facial nerve neurinoma limited to the cerebello-pontine angle/internal auditory  canal: clinico-diagnostic approach and surgical management J. Galli, M. Rigante, F. Bussu,
A. Mangiola, P. De Bonis, C. Parrilla, C. Anile,
G. Paludetti,
Italy
10.10-10.18 Facial nerve tumors: radio-surgical correlations L. Garcia-Ibanez, Spain
10.20-10.28 Intratemporal Facial Nerve Schwannoma: Approach and Outcome
CS Kim,
J-J Song, JH Lee, SH Oh, SO Chang, Korea
09.00 - 10.30
INTRAOPERATIVE FACIAL NERVE MONITORING:
TECHNICAL ERRORS AND MEDICAL-LEGAL OUTCOMES (RUSPOLI 1)
  Chairman: R. Filipo, Italy
Moderator: E. Sargent, USA
Participants: O. Sterkers - France, B. Fraysse - France, S.Whitaker, USA
09.40-09.48 Electrophysiological appraisal of facial nerve with intraoperative microstimulation studies across facial nerve grafting procedures
JK Terzis, K. Tzafetta, USA
09.50-09.58 Predictive value of facial nerve intra operative monitoring for long-term facial function after vestibular schwannoma surgery.
I. Bernat, A. Bozorg Grayeli, M.
 Kalamarides, A. Felice, Z. Zhang, O. Sterkers, France
10.00-10.08 Intraoperative neurophysiological monitoring of facial nerve function during skull base surgery using corticobulbar motor evoked potentials K. Novak, G. Widhalm, V. Malinova,
S. Reitbauer, C. Matula, E. Knosp, Austria
10.10-10.18 Continuous facial nerve CMAP mapping and monitoring as a surgical tool in vascular malformation surgery
TM O, S. Ulkatan, V. Deletis, M. Waner,
USA
10.20-10.28 Three cases showing facial nerve anomalies that were found in operations using Surgical probe T. Yamada, A. Kojima, M. Oh, D. Suzuki, S. Fujieda, Japan
10.30 - 11.00
COFFEE BREAK - POSTERS
11.00 - 12.00
FACIAL NERVE AND MIDDLE EAR SURGERY (PLENARY)
  Chairmen: M. Luntz, Israel, A. Quaranta, Italy
11.00-11.08 Management of Facial Nerve in Petrous Cholesteatoma Surgery
S. Murakami, M. Takahashi, M. Nakayama, S. Esaki, N. Watanabe, N. Aihara, Japan
11.10-11.18 Facial Nerve Palsy as Initial Presentation of Cholesteatoma – Case series and review of the Literature SA Little, SSM Hussain, UK
11.20-11.28 Delayed Facial paralysis after stapedotomy using Diode laser
J-M Gerard, M. Gersdorff, M. Decat, Belgium
11.30-11.38 Facial Nerve Paralysis following Stapedectomy with otological laser PE Hammerschlag, USA
11.40-11.48 Treatment of facial nerve in petrous bone cholesteatoma surgery N. Quaranta, M. Altamura, P. Berardi, A. Quaranta, Italy
11.50-11.58 Giant cholesteatoma of the Temporal Bone: Report of Two Cases Michal Luntz, Rabia Shihada, Alexander Brodsky, Israel
11.00 - 12.00
CLINICAL ISSUES – 1 (CAETANI)
  Chairmen: R. Bento, Brazil - U. Fisch, Switzerland
11.00-11.08 Correlation between gadolinium enchancement and edematous swelling of facial nerve in Bell’s palsy and Hunt syndrome
M. Komori, N. Yanagihara, K. Kashiba, N. Hato,
S. Murakami, Japan
11.10-11.18 Delayed Facial Nerve Palsy after Endolymphatic Sac Surgery
HX Xu, AF Deroee, S. Joglekar, N. Pollak, F. Hobson,
T. Santori, E. Snisarenko, MM Paparella, USA
11.20-11.28 Herpes Zoster Oticus: Treatment and Outcomes
SE Coulson, GR Croxson, V Oey
, Australia
11.30-11.38 Facial Palsy caused by a temporal bone primitive neuroectodermal tumor R. Ferreira Bento , M. Hausen Pinna, RV de Brito Neto, R. Salomone, V. Odone Fillho, Brazil
11.40-11.48 Infective Causes of Facial Nerve Paralysis
SE Coulson, TP Makeham, GR Croxson, Australia
11.50-11.58 Intratemporal Facial Nerve Hemangioma
H-W Yuen, JM Nedzelski, Canada
11.00 - 12.00
CLINICAL ISSUES – 2 (RUSPOLI 1)
  Chairmen: S. Sellari-Franceschini, Italy – V. Darrouzet, France
11.00-11.08 Unilateral rhinorrhea and hyperlacrimation occuring during exercises after surgery of the CPA with facial nerve dissection.
E. Sauvaget, JC. Willer, P. Tran Ba Huy,
France
11.10-11.18 Facial Nerve Palsy in Newborns Secondary to Forceps Use
M. Duval, SJ Daniel, Canada
11.20-11.28 Spontaneous Cerebrospinal Fluid Fistula Through a Congenitally Patent Facial Nerve Canal: Report of 2 Cases
J. Sayeux, V. Franco-Vidal, V. Darrouzet, France
11.30-11.38 Facial Nerve paralysis in children SJ Daniel, Canada
11.40-11.48 Congenital Familial Isolated Facial Palsy- case report.
A. Santoro, S. Sellari
Franceschini , G. Salimbeni, Italy
11.50-11.58 The Facial nerve in Tuberculous Otitis Media
M. Kameswaran, K. Natarajan,
S. Raghunandhan, India
12.00 - 13.00
FACIAL NERVE DECOMPRESSION (PLENARY)
  Chairmen: G. Danesi, Italy, R. Urquiza, Spain
12.00-12.08 Indications  and techniques of facial nerve decompression
NK Panda.
SC Sharma, India
12.10-12.18 Timing and Technique for Facial Nerve Decompression
T. Ulug, Turkey
12.20-12.28 Is Really the Metal Decompression Release Conduction Block of the Facial Nerve?
S. Murakami, K. Yamano, S. Esaki, N. Aihara, Japan
12.30-12.38 A new easier technique to decompress the labyrinthine segment of facial nerve V.Honnurappa, India
12.40-12.48 Recurrent Facial Paralysis; The Role of Surgery
RM Irving, J. Doshi, UK
12.50-12.58 Facial nerve decompression surgery with a basic fibroblast growth factor impregnated biodegradable hydrogel N. Hato,
H. Komobuchi, N. Saawi, M. Teraoka, K. Gyo, Japan
12.00 - 13.00
MEDICAL TREATMENT (CAETANI)
  Chairmen: M. Hultcrantz, Sweden, N.K. Panda, India
12.00-12.08 Corticosteroids versus corticosteroids plus antiviral agents in the treatment of Bell’s palsy: a systematic review and meta-analysis JK Goudakos, KD Markou, Greece
12.10-12.18 Prednisolone and valacyclovir in Bell’s palsy: a randomized, double-blind, placebo-controlled, multicenter trial
M. Engström, T. Berg, A.Stjernquist-Desatnik, S. Axelsson, A. Pitkäranta, M. Hultcrantz, M. Kanerva, P. Hanner,
L. Jonsson - Sweden, Finland
12.20-12.28 Physical therapy and drugs in treatment of peripheral facial palsy: retrospective study.
B. Krofli
č, I. Plaskan, M. Četina, N. Kroflič, Croatia
12.30-12.38 Prognostic factors in patients with Bell’s palsy treated with prednisolone and/or valacyclovir S. Axelsson, T. Berg, M. Engström, L. Jonsson, A. Stjernquist-Desatnik, Sweden
12.40-12.48 The course of pain in Bell’s palsy: treatment with prednisolone and valacyclovir T. Berg, S. Axelsson, M. Engström, A. Stjernquist-Desatnik, M. Kanerva, A. Pitkäranta, L. Jonsson, Sweden, Finland
12.50-12.58 Background for successful early medical rehabilitation of patients with Bell's Palsy A. Demsar, L. Plaskan -  Slovenia
12.00 - 13.00
BOTULINUM TOXIN TREATMENT (RUSPOLI 1)
  Chairmen: SR Saeed, UK -  GA Bertoli, Italy
12.00-12.08 Botulinum A toxin in Facial Paralysis Sequelae J. De-Rossi, R. Salomone, CP Fagundes, LFR Lima, RF Bento, Brazil
12.10-12.18 Botulinum Toxin (BTXA) to improve symmetry in Facial Nerve Palsy SA Sadiq, SR Saeed, UK
12.20-12.28 Persistent diplopia after Botulinum Toxin (BTXA) induced ptosis – comparison of 2 injection sites SA Sadiq, UK
12.30-12.38 Combined protocol for treatment of secondary effects from FN palsy. S. Monini, A. Buffoni, M. Biagini, A. De Carlo, M. Barbara, Italy
12.40-12.48 Limits and undesired effects of botulinum toxin in FN disease treatment I. Spahiu, GA Bertoli, M. Nicastri, R. Filipo, Italy
12.50-12.58 Facial synkinesis and botulinum toxin therapy E. Dalla Toffola,
M. Bejor, E.
Prestifilippo, F. Furini, C. Redaelli, Italy
13.00 - 14.20
          LUNCHEON WORKSHOP - ADVANCE BIONICS (PLENARY)
13.00 - 14.20
BELL’S SOCIETY LUNCHEON OF BOARD OF DIRECTORS
14.30 - 15.20
INSTRUCTIONAL COURSES
PLENARY Management of iatrogenic and traumatic facial nerve injuries
T. Linder, Switzerland
CAETANI Surgical rehabilitation for recent paralysis F. Biglioli, Italy
RUSPOLI 1 Childhood facial paralysis SS Musher-Hussain, UK
RUSPOLI 2 Management of facial nerve in glomus jugularis surgery
F. Memari, Iran
RUSPOLI 3 Management of facial nerve in temporal bone tumours
R. Pareschi, Italy
15.30 - 16.20
INSTRUCTIONAL COURSES
PLENARY The attempt to move from good to great in facial nerve rehabilitation T. Hadlock, M.Cheney, USA
CAETANI Surgical rehabilitation for ancient facial paralysis
A. Takushima, Japan
RUSPOLI 1 Management of the facial nerve in translabyrinthine surgery
D. Moffat, UK
RUSPOLI 2 Facial nerve reconstruction in extra- an intracranial lesions
G. Danesi, Italy
RUSPOLI 3 Patient safety. Concept, methodology and its application in facial nerve surgery F. Rodriguez Pereira, R. Urquiza, Spain
16.30 - 17.00
COFFEE BREAK - POSTERS
17.00 - 18.00
VESTIBULAR SCHWANNOMA SURGERY – 1 (PLENARY)
  Chairmen: P. Møller, Norway, N. Marangos, Greece
17.00-17.08 Does cyclin D1 expression predict facial function outcome in vestibular schwannoma surgery? L. Lassaletta, L. Del Río,
M. Patrón, M. Torres, JA Rey, J. Gavilan, Spain
17.10-17.18 Facial nerve outcome in vestibular schwannoma related to surgical approach.
N. Marangos, A. Papadopoulos,  A. Papadopoulos, Greece
17.20-17.28 Facial nerve function after treatment with microsurgery or Gamma-knife radiation in Vestibular Schwannomas.
P. Møller, E. Myrseth, M. Lund Johannessen,
 Norway
17.30-17.38 How to Preserve the Facial Nerve in Acoustic Neuroma Surgery 
S.Murakami, N. Watanabe, M. Takahashi, A. Inagaki,
M. Nakayama, N.
Aihara, Japan
17.40-17.48 Facial nerve outcomes in translabyrinthine approaches for vestibular schwannoma T. Sorrentino, M.N. Calmels,
S. Lagleyre, M. Marx,  S. Boetto, M.
Tremoulet, O. Deguine, B. Fraysse, France
17.50-17.58 Is facial nerve at risk in hearing preservation surgery? A. Mazzoni, F. Biroli, C. Foresti, A. Signorelli, Italy
17.00 - 18.00
VESTIBULAR SCHWANNOMA SURGERY – 2 (CAETANI)
  Chairmen: JM Nedzelski, Canada, G. Babighian, Italy
17.00-17.08 Facial nerve in acoustic neuroma surgery: what the best approach? F. Trabalzini, G. Babighian, Italy
17.10-17.18 Management of facial neuroma J.M. Nedzelski Canada
17.20-17.28 Preserving the facial nerve in the management of vestibular schwannomas: an evolving practise
TPC Martin, R. De, R. Walsh, RM Irving
, UK
17.30-17.38 Facial nerve function following the widened retrolabyrinrthine approach V.Darrouzet, France
17.40-17.48 Facial nerve preservation during neurosurgical procedures
E. Gaber, Saudi Arabia
18.00 - 18.45
PANEL: TREATMENT OF FACIAL NERVE IN DIFFERENT APPROACHES
FOR REMOVAL OF VESTIBULAR SCHWANNOMA (PLENARY)
  Chairman: A. Mazzoni, Italy
  Moderator: P. Tran Ba Huy, France
  Participants: DE Brackmann, USA, M. Samii, Germany, E. Garcia-Ibanez, Spain
21.00
GALA DINNER: OLGIATA GOLF CLUB, Largo Olgiata 15, 00123 Roma